These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2203215)

  • 1. [The effect of dipyridamole on the results of allogenic kidney transplantation].
    Schulze R; Langkopf B; Sziegoleit W
    Z Urol Nephrol; 1990 May; 83(5):255-9. PubMed ID: 2203215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts.
    Mathew TH; Clyne DH; Nanra RS; Kincaid-Smith P; Saker BM; Morris PJ; Marshall VC
    Lancet; 1974 Jun; 1(7870):1307-10. PubMed ID: 4134294
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment techniques of harvesting injury of donor renal blood vessels].
    Zhang B; Zhang SZ; Wang H; Zhang G; Li X; Qin WJ; Yang XJ; Wu GJ
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):607-10. PubMed ID: 15265405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of transplant renal artery stenosis.
    Kauffman HM; Sampson D; Fox PS; Doyle TJ; Maddison FE
    Surgery; 1977 Feb; 81(2):161-7. PubMed ID: 319550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
    Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
    Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal allotransplantation in humans. Collective review and case reports.
    Arana VA; Menno AD
    Nebr State Med J; 1971 Aug; 56(8):327-43. PubMed ID: 4398273
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of plasmapheresis in kidney transplantation--a controlled study].
    Vangelista A; Frascà GM; di Felice A; Liviano d'Arcangelo G; Bonomini V
    Z Urol Nephrol; 1986 Jun; 79(6):311-6. PubMed ID: 3529744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does initial graft function in cadaveric renal transplantation have a benefit for the 1-year graft survival rate?
    Albrecht K; Niebel W; Erhard J; Eigler FW
    Transplant Proc; 1988 Oct; 20(5):931. PubMed ID: 3055533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation.
    Schneeberger H; Schleibner S; Illner WD; Messmer K; Land W
    Clin Transpl; 1993; ():219-32. PubMed ID: 7918155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled study.
    Frascà GM; Vangelista A; Raimondi C; Bonomini V
    Life Support Syst; 1986; 4(3):231-7. PubMed ID: 3537545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal graft survival in children with early acute rejection.
    Muñoz R; Romero B; Medeiros M; Zaragoza L
    Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.